Despite the loss of Akt1 or Akt2, the mammary tumors from MTB-IGFIR/Akt1−/− and MTB-IGFIR/Akt2−/− mice had levels of phosphorylated Akt similar to the mammary tumors that developed in MTB-IGFIR mice. This evidence concerns the gene AKT1 and breast cancer.